Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, Hiv-1-Infected Adults: 48-Week Results From the Assert Study
AuthID
P-003-3H6
P-003-3H6